Genelux (GNLX) Return on Equity [ROE] (2023 - 2026)
Genelux (GNLX) posted Return on Equity [ROE] of -196.54% for Q1 2026, down 87.39 percentage points from -109.15% a year earlier but up 19.17 percentage points from the prior quarter.
Powered by 
Analysis
Genelux (GNLX) Return on Equity [ROE] (2023 - 2026) Analysis & Trends
For FY2025, Genelux's Return on Equity [ROE] came in at -171.89%, down 36.38 percentage points from FY2024.
- In prior years, Genelux's Return on Equity [ROE] was -135.51% in FY2024.
- Quarterly Return on Equity [ROE] has run from a low of -215.72% in Q4 2025 to a high of -78.94% in Q3 2024 over five years.
- On a year-over-year basis, Return on Equity [ROE] has declined in each of the last four quarters, with an average year-over-year change of -32.48 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2025, with a gain of 36.19 percentage points; the weakest was Q4 2025, with a drop of 111.80 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -215.72% (Q4 2025), -154.23% (Q3 2025) and -117.10% (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | - |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 4.97% |
| 10 | Genelux | 88.08 Mn | 26.36 Mn | - | -196.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -196.54% |
| Dec 31, 2025 | -215.72% |
| Sep 30, 2025 | -154.23% |
| Jun 30, 2025 | -117.10% |
| Mar 31, 2025 | -109.15% |
| Dec 31, 2024 | -103.92% |
| Sep 30, 2024 | -78.94% |
| Jun 30, 2024 | -100.67% |
| Mar 31, 2024 | -145.34% |
| Dec 31, 2023 | -109.74% |
| Sep 30, 2023 | -87.86% |
| Jun 30, 2023 | -80.80% |
API Access
Genelux Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GNLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "GNLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GNLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();